HIV-1 Induces the Formation of Stable Microtubules to Enhance Early Infection  by Sabo, Yosef et al.
Cell Host & Microbe
ArticleHIV-1 Induces the Formation
of Stable Microtubules
to Enhance Early Infection
Yosef Sabo,1 Derek Walsh,2 Denis S. Barry,3,6 Sedef Tinaztepe,1,4 Kenia de los Santos,1 Stephen P. Goff,1
Gregg G. Gundersen,5 and Mojgan H. Naghavi1,3,*
1Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, New York, NY 10032, USA
2Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA
3Centre for Research in Infectious Diseases, University College Dublin, Dublin 4, Ireland
4Department of Genetics and Development, Columbia University, New York, NY 10032, USA
5Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA
6Present address: The Department of Anatomy, Trinity College Dublin, Dublin 2, Ireland
*Correspondence: mn2034@columbia.edu
http://dx.doi.org/10.1016/j.chom.2013.10.012SUMMARY
Stable microtubule (MT) subsets form distinct net-
works from dynamic MTs and acquire distinguishing
posttranslational modifications, notably detyrosina-
tion and acetylation. Acting as specialized tracks
for vesicle and macromolecular transport, their for-
mation is regulated by the end-binding protein EB1,
which recruits proteins that stabilize MTs. We show
that HIV-1 induces the formation of acetylated and
detyrosinated stable MTs early in infection. Although
the MT depolymerizing agent nocodazole affected
dynamic MTs, HIV-1 particles localized to nocoda-
zole-resistant stable MTs, and infection was mini-
mally affected. EB1 depletion or expression of an
EB1 carboxy-terminal fragment that acts as a domi-
nant-negative inhibitor of MT stabilization prevented
HIV-1-induced stable MT formation and suppressed
early viral infection. Furthermore, we show that the
HIV-1 matrix protein targets the EB1-binding protein
Kif4 to induce MT stabilization. Our findings illustrate
how specialized MT-binding proteins mediate MT
stabilization by HIV-1 and the importance of stable
MT subsets in viral infection.
INTRODUCTION
Long-range intracellular transport involves directed cargomove-
ment by motor proteins on microtubules (MTs) (Dodding and
Way, 2011). MTs are composed of a-tubulin/b-tubulin heteropol-
ymers that form polarized filaments whose minus ends are
anchored at the perinuclear MT-organizing center (MTOC), while
their more dynamic plus ends extend toward the plasma mem-
brane (Li and Gundersen, 2008). Although most MTs in many
cell types are highly dynamic, allowing them to explore the intra-
cellular environment through a ‘‘search and capture’’ process,
subsets of these MTs become highly stable. Stable MTs acquire
distinguishing posttranslational modifications, including detyro-
sination and acetylation, and are recognized by specific motorCell Host &proteins to act as specialized tracks for vesicle trafficking (Janke
andBulinski, 2011). As detyrosination exposes a glutamic acid at
the carboxyl terminus of tubulin, these subsets are also known
as Glu-MTs. MT stabilization is regulated by MT plus-end
tracking proteins (+TIPs) that are recruited to dynamic MT
ends by the end-binding protein EB1 (Gouveia and Akhmanova,
2010). +TIPs interact with a range of proteins, including cortical
actin to link MTs to the cell cortex, while localized signaling
controls +TIP function, thereby inducing MT stabilization at
specific subcellular sites (Janke and Bulinski, 2011; Li and Gun-
dersen, 2008).
Viruses have evolved a variety of strategies to hijack cytoskel-
etal networks to facilitate their movement (Dodding and Way,
2011). Retroviruses use actin microfilaments for short-range
transport at the cell periphery and MT motors for long-range
intracellular movement (Campbell and Hope, 2005; Naghavi
and Goff, 2007). Although little is known about early postentry
trafficking of retroviral cores, the HIV-1 reverse transcription
complex (RTC) interacts with both actin and MT cytoskeletons
(Bukrinskaya et al., 1998; Contreras et al., 2012; McDonald
et al., 2002), suggesting that viral proteins function in early
actin-mediated movement and the transition of viral cores to
theMT network. Retroviral particlesmove in a dynein-dependent
manner along MTs to the nucleus, with uncoating and RT
thought to occur during MT-dependent trafficking or upon
reaching the nucleus (Arhel et al., 2006; 2007; McDonald et al.,
2002; Petit et al., 2003; Su et al., 2010). While numerous screens
have identified cytoskeletal factors as regulators of infection, our
recent screens specifically identified regulators of MT stability
(Haedicke et al., 2008; Henning et al., 2011; Naghavi et al.,
2007). However, these factors are broad regulators of both actin
andMT organization, and as such, our understanding of the spe-
cific contribution of stable MTs to infection remains limited.
Here we show that HIV-1 induces MT stabilization early in
infection of a number of human cell types. Incoming viral parti-
cles associated with stable MTs even in the presence of nocoda-
zole, suggesting an underappreciated role for these MT subsets
in early infection. By depleting EB1 or expressing a dominant-
negative inhibitor of +TIP recruitment to EB1, we show that
EB1 promotes HIV-1 infection after fusion of viral cores into the
cytoplasm through effects on stable MTs. In EB1-depleted cells,Microbe 14, 535–546, November 13, 2013 ª2013 Elsevier Inc. 535
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Figure 1. HIV-1 Induces Acetylated MT Formation in Human Cells
(A–D) Cells were infected with HIV-1, then samples were fixed at the indicated h.p.i. and stained for Tyr-MTs and AC-MTs. U87.CD4.CCR5 cells were mock
infected or infected at moi 3 with HIV-1 carrying HIV-1 envelope (A); NHDFs (B), CHME3 cells (C), or primary human macrophages (D) were mock infected or
infected with HIV-1-VSV. Images are shown for representative time points of 2 h.p.i. and 6 h.p.i. Scale bar = 10 mm.
(E and F) WB analysis of AC-MT levels in mock-infected and HIV-1-VSV-infected jurkat cells (E) and primary human macrophages (F) at the indicated h.p.i. eIF4E
was used as loading control. See also Figure S1.
Cell Host & Microbe
Microtubule Stabilization by HIV-1HIV-1 particles failed to reach the nucleus. Finally, we demon-
strate that HIV-1 matrix (MA), a component of incoming viral
particles and of the Gag polyprotein, targets the EB1-binding
protein Kif4 to induce MT stabilization. Our findings illustrate
how HIV-1 has evolved to target specialized +TIPs to control
MT stability and promote early postentry stages of infection.
RESULTS
HIV-1 Infection Induces MT Stabilization
To determine whether HIV-1 affects MT stability, cells were in-
fected with viruses carrying HIV-1 envelope or either of two inde-
pendent envelopes widely used for pseudotyped infection. Cells
were fixed at various times in hours postinfection (h.p.i.) and
stained for tyrosinated (Tyr-MTs) or acetylated (AC-MTs) tubulin.
While no detectable differences in Tyr-MTs were observed
between uninfected and infected samples, immunofluorescence
(IF) demonstrated that HIV-1 carrying wild-type (WT) envelope
induced AC-MT formation in U87.CD4.CCR5 cells (Figure 1A).536 Cell Host & Microbe 14, 535–546, November 13, 2013 ª2013 ElsTo test whether this was cell type dependent or envelope depen-
dent, different cell types were mock infected or infected with
HIV-1 pseudotyped with vesicular stomatitis virus G envelope
glycoprotein (HIV-1-VSV). IF analysis demonstrated that HIV-1
induced AC-MT formation in primary normal human dermal
fibroblasts (NHDFs) (Figure 1B) and 293A cells (Figure S1A avail-
able online), as well as in natural target cell types, human micro-
glia (CHME3), and primary humanmacrophages (Figures 1C and
1D). This was confirmed by quantification of fluorescence inten-
sity of AC-MTs (Figures S1B–S1E) or by determining the percent-
age of AC-MT-positive cells (Figure S1F). Furthermore, although
IF analysis in T cells is complicated by their small cytoplasm, AC-
MT induction byHIV-1was readily detected bywestern blot (WB)
analysis of mock-infected or infected Jurkat cells, a human T cell
lymphoblast-like cell line (Figure 1E), as well as primary human
macrophages (Figure 1F). Heat-inactivated virus (Figures S1G
and S1H) or viruses lacking envelope glycoproteins that cannot
enter cells (Figures S1I and S1J) did not induce AC-MTs. As viral
particles without envelope cannot be titered, WB analysis of Gagevier Inc.
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Figure 2. Nocodazole Depolymerizes Dynamic MTs and Modestly Reduces Infection by HIV-1
(A–D) Cells were treated for 1 hr with either DMSO or increasing concentrations of nocodazole (0.1–10 mM). 293A cells were infected at moi 3 with HIV-1-VSV-
ZsGreen (A) or HIV-1-Ampho-ZsGreen (B) and CHME3 cells with HIV-1-VSV-ZsGreen (C) or HIV-1-Ampho-ZsGreen (D), followed by FACS analysis of ZsGreen-
positive cells. Nocodazole-treated samples were normalized to DMSO-treated negative controls to determine the percentage of infectivity.
(E and F) DMSO- or nocodazole-treated 293A (E) or CHME3 (F), as in (A)–(D), were fixed and stained for Tyr-MTs and AC-MTs 1 hr posttreatment. Images are
shown for representative nocodazole concentrations, as indicated. Scale bar = 10 mm.
Cell Host & Microbe
Microtubule Stabilization by HIV-1protein levels was used to normalize amounts of enveloped and
nonenveloped virions used for infections (Figure S1K). Finally, IF
analysis showed that HIV-1 also induced the formation of detyr-
osinatedMTs (Figure S1L), andWBanalysis confirmed increases
in both AC- and Glu-MTs in HIV-1-infected samples (Figures
S1M and S1N). The acquisition of both modifications demon-
strated that HIV-1 inducedMT stabilization, rather than a singular
tubulin modification, and further evidence of MT stabilization
is presented below. Differences in the kinetics of induction
matched known differences in the kinetics of entry mediated
by different envelope glycoproteins (Hulme et al., 2011), sug-
gesting that it occurred postentry.
HIV-1 enters the cell by either membrane fusion or endocytosis
(Miyauchi et al., 2009). Pseudotyping allows these distinct routes
to be tested. HIV-1-VSV, used above, enters the cell by endocy-
tosis. To further confirm that MT stabilization was envelope inde-
pendent, murine leukemia virus (MuLV) amphotropic envelope,
which induces fusion at the cell surface, was used to pseudotype
HIV-1 (HIV-1-Ampho).Similar toHIV-1andHIV-1-VSV,HIV-1-Am-
pho inducedMTstabilization in varioushumancells (FiguresS1O–
S1T). MT stabilization by HIV-1-Ampho was delayed compared
with HIV-1-VSV, consistent with the kinetics of entry by fusion at
the cell surface being slower than entry via the endocytic pathwayCell Host &(Hulme et al., 2011). These findings showed that HIV-1 induced
MTstabilization indifferent humancell types regardlessof the viral
envelope and entry pathway, starting as early as 1–2 h.p.i.
Nocodazole Does Not Disrupt Stable MTs and Only
Moderately Reduces HIV-1 Infection
The MT depolymerizing agent nocodazole has been reported to
exert only small effects on various stages of HIV-1 infection (Jou-
venet et al., 2006; Yoder et al., 2011). However, stable MTs are
highly resistant to nocodazole, and as such, their importance
to infection may be underestimated. To test this, the effects of
nocodazole on infectivity and MT organization were examined.
For infection, cultures were treated for 1 hr with 0.1–10 mM
nocodazole, spanning the range used in previous studies, then
infected with HIV-1-VSV or HIV-1-Ampho in the presence of
nocodazole. In line with previous reports, nocodazole only
moderately reduced infection of two different cell types by pseu-
dotyped viruses that enter the cell by distinct routes (Figures 2A–
2D). Although dynamic Tyr-MTs were depolymerized at 0.1–
1 mM nocodazole, significant levels of stable AC-MTs persisted
even at the highest concentrations tested (Figures 2E and 2F).
While the modest reduction in HIV-1 infection caused by noco-
dazole correlated with depolymerization of dynamic MTs,Microbe 14, 535–546, November 13, 2013 ª2013 Elsevier Inc. 537
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Figure 3. HIV-1 Localizes to Stable MTs in the Presence of Nocodazole
(A) CHME3 cells were infected with HIV-1-VSV-GFP-Vpr at moi 1 for 4 hr. Cultures were fixed and stained for Tyr-MTs (blue), AC-MTs (red), and GFP (green).
Arrows point to viral particles localized to AC-MT networks. Orthogonal views are presented above and to the left of each regular imaging plane (top x-z, left z-y);
scale bar = 10 mm.
(B) Cells were infected with HIV-1-VSV-GFP-Vpr for 2 hr and then fixed and stained for GFP and HIV-1 p24. Arrows point to representative viral particles that
costain for both proteins.
(C) Quantification of the percentage of viral particles associated with AC-MTs, represented as mean ± SEM at 1, 2, and 4 h.p.i. in CHME3 cells infected as in (A).
(D) CHME3 cells were treated with 0.25 mMnocodazole for 20min and then infected for 1 hr with HIV-1-VSV-GFP-Vpr and processed as in (A). Arrows indicate the
localization of virions to AC-MTs. Scale bar = 10 mm.
Cell Host & Microbe
Microtubule Stabilization by HIV-1nocodazole-resistant stableMTs could explain the relatively high
levels of infectivity that persist in treated cells.
We next examined whether incoming virions localize to stable
MTs by infecting CHME3 cells with HIV-1-VSV carrying GFP-
tagged Vpr (McDonald et al., 2002). Titration of our virus pre-
parations for p24 content by WB analysis suggests that the
particle-to-plaque-forming units (pfu) ratio was typically in the
range of 1,000:1; thus, infecting cells at a multiplicity of 1
represents the addition of about 1,000 physical particles. While
only a small fraction of the applied virions mediate all steps
required for successful infection, we image all of them. Fixed
samples were stained for GFP, Tyr-MTs, and AC-MTs and then
imaged using confocal microscopy. IF analysis revealed that
viral particles localized to AC-MT networks in infected cells (Fig-
ure 3A). Costaining for HIV-1 p24 revealed that GFP-Vpr-positive
particles represented virus at various stages of infection (Fig-
ure 3B); at the 2 hr point tested, many were still in early stages538 Cell Host & Microbe 14, 535–546, November 13, 2013 ª2013 Elsand exhibited colocalization with p24, while p24 was lost
from viral particles that had uncoated (Hulme et al., 2011). p24
puncta that did not stain for GFP-Vpr likely represent natural
subpopulations of virus that do not acquire significant amounts
of the GFP-Vpr marker. Quantification of the number of viral
particles on AC-MTs revealed that 20% were associated with
stable MTs by 1 h.p.i., as viral particles began entering the cell,
and reached 50% by 2 h.p.i. and 90% by 4 h.p.i (Figure 3C).
The kinetics with which the percentage of viral particles asso-
ciated with AC-MTs increased was similar to the kinetics of
AC-MT induction by HIV-1 (Figure 1), suggesting that incoming
viral particles induce and associate with stable MTs. Finally, to
test whether stable MTs might contribute to HIV-1’s relative
insensitivity to nocodazole, CHME3 cells were treated for
20 min with nocodazole and then infected with HIV-1-VSV-
GFP-Vpr. While nocodazole disrupted dynamic MTs (Figures
2F and 3D), IF analysis showed that HIV-1 particles continuedevier Inc.
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Figure 4. EB1 Is Required for HIV-1-Mediated MT Stabilization and Infection
(A and B) NHDFs were transfected with control GFP siRNA (A) or EB1 siRNA (B) and then noninfected (N.I.), mock-infected, or infected with HIV-1-VSV at moi 3.
Samples were fixed at the indicated h.p.i. and stained for Tyr-MTs and AC-MTs. Images are shown for representative fields. Scale bar = 10 mm.
(C–E) NHDFs were transfected with control GFP siRNA or two independent EB1 siRNAs (EB1-II and EB1-III) and then infected with HIV-1-VSV-Luc (C) or HIV-1-
Ampho-Luc (D). Levels of infection were determined by luciferase assay. (E) WB analysis demonstrated the extent of EB1 depletion in samples. eIF4E served as a
loading control.
(F–H) CHME3 cells were transfected with control, EB1-II, or EB1-III siRNAs and then infected with HIV-1-VSV-Luc. (F) Luciferase assays were used to determine
levels of infection. (G) qPCR showing EB1 transcript levels in each sample. (H) WB analysis of EB1 depletion in samples. GAPDH served as a loading control.
(I and J) Jurkat cells were treated with control or EB1-II siRNAs and infected with HIV-1-VSV-Luc. (I) Luciferase assays were used to determine levels of infection.
(J) WB analysis of EB1 depletion and AC-MTs in samples. eIF4E was used as loading control. Data in (C), (D), (F), (G), and (I) are represented as mean ± SEM. See
also Figure S2.
Cell Host & Microbe
Microtubule Stabilization by HIV-1to localize to AC-MTs in treated cells (Figure 3D). These findings
showed that while dynamic MTs support a modest level of infec-
tion, HIV-1 induces and associates with stable MT subsets early
in infection and in nocodazole-treated cells.
EB1 Is Required for HIV-1-Induced MT Stabilization and
Viral Infection
EB1 is a central regulator of both MT dynamics and stabilization
(Gouveia and Akhmanova, 2010). To determine whether it was
required for HIV-1-induced MT stabilization, siRNAs were used
to deplete EB1 in NHDFs prior to infection. IF analysis showed
that in control siRNA-treated cultures, HIV-1 induced AC-MTs
at 2 and 6 h.p.i., and this induction was blocked by EB1 depletion
(Figures 4A, 4B, and S2). To determine the impact of preventing
EB1-mediated MT stabilization on infection, siRNA-treated
cultures were infected with luciferase reporter viruses. Lucif-
erase assays revealed that compared to control siRNA-treated
cultures, EB1 depletion using either of two independent
siRNAs potently reduced infection by HIV-1-VSV or HIV-1-
Ampho in both NHDFs (Figures 4C and 4D) and CHME3 cellsCell Host &(Figure 4F), demonstrating that effects were independent of the
viral entry pathway. Furthermore, WB (Figures 4E and 4H) and
quantitative PCR (Figure 4G) analysis showed that effects on
infection correlated with the levels of EB1 depletion achieved
with each siRNA. We have observed that Jurkat T cells express
very high levels of EB1 and contain high levels of AC-MTs
compared with other cell types tested. However, even partial
depletion of EB1 detectably reduced AC-MT levels and resulted
in a corresponding decrease in HIV-1 infection (Figures 4I and
4J). This demonstrated that EB1 is a critical regulator of MT sta-
bilization and infection by HIV-1 in several cell types.
EB1 Influences HIV-1 Infection through Its Effects on
Stable MTs
To further test the role of MT stabilization, we generated a human
version of a previously described carboxy-terminal fragment of
mouse EB1 (EB1-C) (Wen et al., 2004). EB1-C contains the
C-terminal region that binds +TIPs but lacks the N-terminal MT
binding domain. As such, EB1-C does not interfere with dynamic
MTs but binds +TIPs and competitively blocks their recruitmentMicrobe 14, 535–546, November 13, 2013 ª2013 Elsevier Inc. 539
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Figure 5. Stable Expression of a Dominant-Negative Carboxy-Terminal Fragment of EB1 Inhibits MT Stabilization and HIV-1 Infection in
CHME3 Cells
(A) WB analysis of EB1 (upper panel) or transgene EB1 (lower panel) levels in CHME3 cells stably expressing control Flag, EB1-Flag, or dominant-negative EB1-C-
Flag using anti-EB1 or anti-Flag antibodies.
(B and C) IF analysis of Tyr-MTs and AC-MTs in representative clones of Flag, EB1-Flag (E2:2), or EB1-C-Flag (C2:2) either mock infected or infected at moi 3 with
HIV-1-VSV (B) or HIV-1-Ampho (C). Cultures were fixed and stained for Tyr-MTs and AC-MTs at 6 h.p.i. Scale bar = 10 mm.
(D and E) Flag, EB1-Flag, or EB1-C-Flag clones were infected with HIV-1-VSV-luc (D) or HIV-1-Ampho-luc (E) followed by the measurement of luciferase activity
48 h.p.i. to determine levels of infection (upper panels). Data are represented as mean ± SEM. Stable MT levels in infected clones 6 h.p.i. were determined byWB
using anti-acetylated tubulin antibody (AC-MTs) (middle panels). eIF4E served as a loading control (lower panels).
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Microtubule Stabilization by HIV-1to endogenous EB1, thereby acting as a dominant-negative
inhibitor of MT stabilization (Wen et al., 2004). CHME3 lines
expressing Flag-tagged human EB1 (EB1-Flag), Flag-tagged
EB1-C (EB1-C-Flag), or Flag alone were generated. WB analysis
using anti-Flag antibody confirmed the expression of EB1-Flag
and EB1-C-Flag in two independent clones (Figure 5A). To deter-
mine expression levels of exogenous forms of EB1 relative to
endogenous EB1, we used anti-EB1 antibody (Figure 5A). EB1-
Flag exhibited reduced mobility in SDS-PAGE and was
expressed to levels at or above those of endogenous EB1.
EB1-C-Flag could not be detected using anti-EB1 antibody, as
it lacks the target epitope. However, anti-Flag WB indicated
that the level of EB1-C-Flag expression was significantly lower
than that of EB1-Flag and, as such, was significantly lower
than that of endogenous EB1. To determine the effects of EB1-
Flag and EB1-C-Flag on MT stabilization by HIV-1, these lines
were infected, fixed, and stained for Tyr-MTs and AC-MTs.
AC-MTs were increased in a Flag clone infected with HIV-1-
VSV or HIV-1-Ampho, and a more pronounced increase
occurred in a clone expressing EB1-Flag (Figures 5B and 5C),
demonstrating that EB1 facilitated HIV-1-induced MT stabiliza-540 Cell Host & Microbe 14, 535–546, November 13, 2013 ª2013 Elstion. By contrast, HIV-1-induced stable MT formation was
partially suppressed in a clone expressing EB1-C-Flag
compared to both Flag-expressing and EB1-Flag clones (Figures
5B and 5C). The relatively low efficiency with which EB1-C-Flag
reduced stable MT induction compared to Flag-expressing lines
reflects the fact that high-level expression over endogenous EB1
could not be achieved, limiting its efficacy as a dominant nega-
tive. Regardless, these findings showed that the expression of
exogenous EB1 or EB1-C was sufficient to modulate stable MT
levels in infected cells.
To determine effects on infection, these clones were infected
with HIV-1-VSV or HIV-1-Ampho reporters. While both EB1-
Flag lines showed a significant increase in infection compared
to the Flag line, both EB1-C-Flag clones exhibited reduced
infection below levels of the control Flag line (Figures 5D and
5E). WB analysis confirmed that EB1-Flag expression enhanced
stable MT levels in these lines and increased infection, while
EB1-C-Flag reduced stable MT levels and reduced infection
(Figures 5D and 5E). Again, effects of EB1-C on viral infection
were partial, in line with modest reductions in stable MT levels
in EB1-C-expressing lines. However, this demonstrated thatevier Inc.
Cell Host & Microbe
Microtubule Stabilization by HIV-1even modest changes in stable MT levels affected HIV-1
infection.
EB1 Promotes an Early Postfusion Stage of HIV-1
Infection
To determine the point in the viral lifecycle affected by EB1,
CHME3 cells were treated with control or EB1 siRNAs. Cultures
were then infected with HIV-1-VSV, and levels of minus-strand
strong stop (MSS) DNA, the first detectable retroviral DNA, as
well as total viral DNA were determined (Henning et al., 2010).
WB analysis confirmed EB1 depletion by targeting siRNAs and
the resulting reduction in Glu-MTs and AC-MTs (Figure 6A).
Quantitative real-time PCR (qPCR) analysis of viral MSS DNA
(Figure 6B) and total viral DNA (Figure 6C) showed that EB1
depletion potently inhibited infection before or at the initiation
of RT and viral DNA synthesis. Envelope-independent effects
on viral infection suggested that EB1 affected postentry stages
of infection. To test this, we used a previously described fusion
assay in which HIV-1 cores containing a b-lactamase-Vpr fusion
protein allow monitoring of viral penetration into the cytosol
(Cavrois et al., 2002). Fusion assays in EB1-Flag and EB1-C-
Flag clones (Figures 6D and 6E) as well as EB1-depleted NHDFs
(Figure 6F) showed that EB1 did not notably affect fusion of HIV-
1 into the cytoplasm. To explore this further, NHDFswere treated
with control or EB1 siRNAs and then infected with HIV-1-VSV-
GFP-Vpr. Because EB1 depletion prevents stable MT formation,
samples were fixed and stained for Tyr-MTs to visualize MT or-
ganization and cell shape and for GFP to detect viral particles.
Confocal microscopy revealed that at 1 h.p.i., viral particles
localized to MTs at the cell periphery in both control and EB1-
depeleted cells (Figure 6G). However, by 4 h.p.i., viral particles
were accumulating near the nucleus in control siRNA-treated
samples but remained near the cell periphery and distant from
the nucleus in EB1-depleted cells. These effects were quantified
in samples taken at 1, 2, and 4 h.p.i. bymeasuring the distance of
viral particles from the nucleus in acquired z stacks, excluding
the rim of the cell in order to ensure that virus had entered (Fig-
ure 6H). Data are presented as the percentage of total viral
particles within the cell that are within 2 mm of the nucleus. Re-
sults showed that control and EB1-depleted cells were indistin-
guishable at 1 h.p.i., with low percentages likely reflecting small
numbers of particles entering the cell at regions of the plasma
membrane proximal to the nucleus. By 2–4 h.p.i., the number
of viral particles within 2 mm of the nucleus increased in control
samples, while this was potently inhibited by EB1 depletion (Fig-
ure 6H). IF analysis confirmed the efficacy of EB1 depletion and
that this blocked AC-MT induction in these assays (Figures S3A
and S3B). This suggested that EB1-mediated MT stabilization
was required for efficient translocation of viral particles across
the cytoplasm.
Kif4 Mediates MT Stabilization and Early Infection by
HIV-1
EB1 regulates MT stabilization by recruiting +TIPs to MT ends.
We recently identified the kinesin Kif4 as an EB1-binding protein
that induces MT stabilization in mouse cells (E.J. Morris, G.
Nader, F. Bartolini, and G.G.G., unpublished data). siRNA-medi-
ated depletion of Kif4 in 293A cells or NHDFs confirmed that Kif4
also regulated MT stability in human cells (Figure 7A). To deter-Cell Host &mine whether Kif4 localized to the ends of stable MTs in HIV-1-
infected cells, 293A or CHME3 cells were infected with HIV-1-
VSV. Cultures were fixed, stained for Kif4 and Glu-MTs, and
then analyzed by total internal reflection fluorescence (TIRF)
microscopy to imageMTs at the cell periphery. TIRFmicroscopy
revealed that Glu-MT endswere decorated with Kif4 puncta (Fig-
ures 7B and 7C), suggesting that Kif4 could facilitate MT stabili-
zation in infected cells.
Previously, Kif4 was found (in a yeast two-hybrid library
screen) to interact with the retroviral Gag polyprotein (Kim
et al., 1998; Tang et al., 1999). The binding site for Kif4 in Gag
has been mapped to MA (Tang et al., 1999). To test whether
Gag or MA affect MT stability, CHME3 cells or NHDFs were
transfected with control plasmid or plasmids expressing HIV-1
Gag or MA. WB analysis showed that expression of either viral
protein resulted in the accumulation of AC-MTs (Figure 7D).
AC-MTs were also increased by expression of MA from simian
immunodeficiency virus (SIV) (Figure S4A), demonstrating that
this was not a property unique to HIV-1 MA. Thus, stable MTs
could be induced not only by introduction of virus proteins by
infection, but also by expression of Gag or MA after transfection.
This latter approach allowed us to test whether MA binding to
Kif4 mediated MT acetylation, as mutations in MA affect viral
particle formation, preventing us from determining its role in
how incoming virions induce AC-MTs. To do this, we tested the
effect of MAmutants in the context of the Gag polyprotein. HeLa
cells were transfected with HA-tagged forms of Gag, followed by
coimmunoprecipitation (coIP) with anti-Kif4 antibody. While WT
Gag, as well as Gag variants with mutations in the N-terminal
myristoylation site or lacking amino acids 112–131 in the
C-terminal region of MA, bound Kif4 and induced AC-MTs, dele-
tion of amino acids 32–51 in the N terminus of MA impaired both
Gag’s interactionwith Kif4 and its ability to induceMT acetylation
(Figures 7E and 7F). This demonstrated thatMAmediated target-
ing of Kif4 by Gag to regulateMT stability and suggested that MA
in incoming viral particles could explain the ability of HIV-1 to
induce MT stabilization early in infection. To test this, Kif4 was
depleted in NHDFs or CHME3 cells, and cultures were infected
with HIV-1-VSV. IF analysis revealed that Kif4 depletion sup-
pressed AC-MT induction byHIV-1 (Figures 7GandS4B). Finally,
depletion of Kif4 inhibited early infection with HIV-1-VSV or HIV-
1-Ampho, as determined by effects on luciferase reporter gene
expression (Figures 7H and 7I, respectively) as well as qPCR
analysis of the levels of viral MSS DNA and total viral DNA (Fig-
ures 7J and 7K, respectively). As such, like EB1, depletion of
Kif4 blocked stable MT formation and early stages of infection
before or at the initiation of RT and viral DNA synthesis.
DISCUSSION
Although MTs typically form highly dynamic networks, recent
work has highlighted the biological importance of stable MT sub-
sets to processes such as cell polarization, differentiation, and
motility. However, the potential importance and regulation of
these specialized MT networks during viral infection remains
poorly understood. Here, we show that HIV-1 rapidly induces
the formation of posttranslationally modified stable MTs and
identify key roles for EB1 and its binding partner, Kif4, in regu-
lating MT stability and early postentry stages of infection.Microbe 14, 535–546, November 13, 2013 ª2013 Elsevier Inc. 541
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Figure 6. EB1 Promotes an Early Postfusion Stage of HIV-1 Infection
(A) Effects of EB1 depletion on HIV-1 DNA synthesis. CHME3 cells were transfected with control GFP siRNA or EB1 siRNA (EB1-II). (A) At 24 hr posttransfection,
cells were lysed and analyzed by WB using antibodies to EB1, Glu-MTs, AC-MTs, or PABP1 (as loading control).
(B andC) At 24 hr posttransfection, cells were infectedwith HIV-1-VSV-puro. Lowmolecular Hirt DNAwas isolated at 24 h.p.i., and levels of viral MSS-DNA (B) and
total viral DNA (C) in samples were measured by qPCR using primers specific to MSS and puromycin, respectively. Copy numbers were calculated and
normalized to input DNA in each sample. Data are represented as mean ± SEM.
(D–F) Effects of EB1 on fusion of HIV-1 cores into the cytosol. CHME3 cells expressing Flag, EB1-Flag (E2:2), or EB1-C-Flag (C2:2) were either mock
infected (upper panels) or infected with HIV-1-VSV-ZsGreen containing BlaM-Vpr (lower panels). (D) FACS analysis of cells infected at a high moi showing13%
shift from green (uncleavedCCF2) to blue (cleaved CCF2) cells in Flag, E2:2, and C2:2 clones. (E) Quantification of the effects of E2:2 and C2:2 onHIV-1 fusion at a
low moi using the BlaM-Vpr assay, normalized to control Flag lines. (F) NHDFs were treated with control GFP or EB1 siRNAs and then infected at a low moi with
(legend continued on next page)
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Microtubule Stabilization by HIV-1HIV-1 associates with MTs soon after fusion of viral cores into
the cytoplasm and travels to the nucleus in a dynein-dependent
manner (Arhel et al., 2006; McDonald et al., 2002). Perhaps para-
doxically, given the limitations to free diffusion in the cytoplasm,
observations that nocodazole has little effect on various stages
of HIV-1 infection have led to suggestions that MTs do not play
an important role in retroviral infection (Jouvenet et al., 2006;
Yoder et al., 2011). However, one study speculated that this
might be due to nocodazole-resistant MTs, although this was
not tested (McDonald et al., 2002). Here, we show that stable
MTs persist in nocodazole-treated cells and that viral particles
localize to theseMT subsets. This suggests that HIV-1 can utilize
stable MTs early in infection and that studies using nocodazole
underestimate their importance to infection. Indeed, indirect
lines of evidence support this; the cytoskeletal crosslinking fac-
tors ezrin and moesin negatively regulate stable MTs and sup-
press retroviral infection (Haedicke et al., 2008; Naghavi et al.,
2007). However, these factors also influence other cellular func-
tions, including actin organization. Furthermore, histone deace-
tylase 6 (HDAC6) deacetylates tubulin and suppresses infection
by HIV-1 (Valenzuela-Ferna´ndez et al., 2005). However, the
direct contribution of MT acetylation to these effects remains
unknown, as HDAC6 regulates many other host functions. Using
both RNAi and dominant-negative approaches to block EB1-
mediatedMT stabilization, we demonstrate the functional impor-
tance of stable MTs to HIV-1 infection. Depleting EB1 prevented
HIV-1-induced MT stabilization and potently inhibited early
infection. Althoughwe could not achieve levels of EB1-C expres-
sion that exceeded endogenous EB1 to potently exert a domi-
nant-negative effect, even the modest reductions in stable MT
levels accomplished with this approach resulted in a corre-
sponding decrease in viral infection. This sharply contrasts
with the effects of nocodazole, wherein potent depolymerization
of dynamicMTs has limited effects on infection. Depletion of EB1
blocked infection after viral fusion but before or at the point of
viral DNA synthesis. A number of actin-MT linking factors (Hae-
dicke et al., 2008; Henning et al., 2010; Leung et al., 2006;
Naghavi et al., 2007) and MT-associated proteins (Gallo and
Hope, 2012) affect a similar postfusion early stage in retroviral
infection. As such, the onset of viral DNA synthesis after entry
of HIV-1 into the cell seems to be intricately linked to the transi-
tion of viral particles from actin to MTs. Indeed, RT is thought to
occur during MT-dependent trafficking to the nucleus (Arhel
et al., 2006; 2007; McDonald et al., 2002; Petit et al., 2003; Su
et al., 2010). Our findings that EB1 depletion blocks MT stabiliza-
tion and inhibits the translocation of HIV-1 particles through the
cytoplasm to the nucleus and blocks RT supports this model and
further suggests that stable MTs are particularly important to
these early stages of infection.
Stable MTs have long half-lives and are recognized by specific
motor proteins to act as specialized tracks for cargo trafficking
(Janke and Bulinski, 2011; Li andGundersen, 2008). These prop-HIV-1-VSV-ZsGreen containing BlaM-Vpr. Samples were analyzed by FACS, an
treated samples.
(G and H) EB1 depletion inhibits the translocation of viral particles across the cytop
infected with HIV-1-VSV-GFP-Vpr at moi 1. (G) After 1 hr or 4 hr, samples we
Representative images are shown. Scale bar = 10 mm. (H) Quantification of the per
represented as mean ± SEM. nR 36 cells, and n > 400 viral particles per sampl
Cell Host &erties make them potentially ideal targets for viruses to reach
their intracellular sites of replication. Indeed, a number of viruses
induce tubulin acetylation, yet whether this represents MT stabi-
lization in each case, the underlying mechanism of induction,
and the contribution to infection remain unclear (Elliott and
O’Hare, 1998; Frampton et al., 2010; Husain and Harrod, 2011;
Jouvenet et al., 2004; Kannan et al., 2009; Naranatt et al.,
2005; Parker et al., 2002; Warren and Cassimeris, 2007; Yea
et al., 2007). Kaposi’s sarcoma-associated herpesvirus (KSHV)
induces MT acetylation within 30 min of infection through integ-
rin-mediated activation of signaling pathways (Naranatt et al.,
2005). Here, we show that HIV-1 rapidly induces MT stabiliza-
tion, as demonstrated by the accumulation of two posttransla-
tional modifications, acetylation and detyrosination, which serve
as distinct markers for MT stabilization. Stabilization occurred
independently of the envelope used or route of viral entry, while
the kinetics of induction by viruses pseudotyped with different
envelopes matched the kinetics of viral entry mediated by these
envelopes (Arhel et al., 2006; Hulme et al., 2011; McDonald et al.,
2002). This suggests that stabilization occurred early after viral
entry. In line with this, MT stabilization was induced by exoge-
nous expression of the viral structural polyprotein Gag or the pro-
cessed Gag subunit, MA, present in incoming particles. Gag and
MA bind the kinesin Kif4 (Kim et al., 1998; Tang et al., 1999). We
have found that Kif4 acts as a MT stabilizing factor and demon-
strate that anN-terminal region ofMAmediates binding of Gag to
Kif4 and efficient AC-MT induction. Furthermore, we show that
Kif4 is required for incoming viral particles to stabilize MTs and
for early stages of viral infection. It is notable thatMT stabilization
is regulated at localized sites at the cell periphery (Li and Gun-
dersen, 2008). The low-level induction of AC-MTs detected by
both WB and IF at 1–2 h.p.i. suggests a model whereby MA pre-
sent in incoming virions triggers localized MT stabilization at or
near the site of virus entry to facilitate very early stages of infec-
tion. Although multiplicities of infection (moi) ranging from 1–3
were used in our studies, our virus preparations typically have
particle-to-pfu ratios in the range of 1,000, and so infected cells
are exposed to many more physical particles. Many of these will
enter cells and contribute to the initial MT stabilization detected
very early in infection. The continued increase in MT stabilization
as infection progresses likely reflects an amplification of this
initial effect, possibly driven by viral proteins released during
uncoating and/or signaling pathways triggered by infection.
Whether stable MTs play a role in later stages of HIV-1 infection
is difficult to discern because the virus induces and requires MT
stabilization early in its lifecycle. However, expression of Gag
polyprotein that is made late in infection also induces MT acety-
lation, as shown here and in a recent report demonstrating that
Gag associates with MTs (Nishi et al., 2009). Notably, interaction
of the MA region of Gag with Kif4 regulates Gag intracellular traf-
ficking and production of virus-like particles (VLPs) (Martinez
et al., 2008). While this might reflect Kif4’s properties as and effects of EB1 depletion on HIV-1 fusion were normalized to control siRNA-
lasm to the nucleus. NHDFswere treated with control GFP or EB1 siRNAs then
re fixed and stained for Tyr-MTs and GFP. Nuclei were stained with DAPI.
centage of virions within 2 mmof the nucleus in infected cells at 1 hr, 2 hr, or 4 hr
e. See also Figure S3.
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Figure 7. Kif4 Mediates MT Stabilization and Early HIV-1 Infection
(A) Kif4 regulates AC-MT levels in human cells. 293A or NHDF cells were transfected with control or Kif4 siRNAs and then analyzed by WB with the indicated
antibodies.
(B and C) TIRFmicroscopy images of infected 293A (B) and CHME3 cells (C). Cells were infected with HIV-1-VSV and then fixed and stained for Kif4 and Glu-MTs.
Kif4 present on Glu-MTs at the periphery of HIV-1-infected cells is indicated by arrows. Higher-magnification images of Kif4 on Glu-MTs are shown in the right
panels. Boxed regions in the merged image are shown at a higher magnification in the lower right panels.
(D) Expression of Gag or MA inducesMT acetylation in human cells. CHME3 or NHDF cells were transfected with control pcDNA, pcDNA-Gag, or pcDNA-MA and
then analyzed by WB using anti-HIV-1 Gag, anti-Kif4, and anti-AC-tubulin antibodies.
(E and F) An N-terminal region of HIV-1 MA mediates binding to Kif4 and MT stabilization. (E) HeLa cells were transfected with HA-tagged forms of Gag and
immunoprecipitated using anti-Kif4 antibody. WB using anti-Kif4 or anti-HA antibodies shows the levels of Kif4 or HIV-1 Gag polyprotein in immune complexes
and input levels of Gag. (F) WB analysis of AC-MT levels in HeLa cells 48 hr after transfection with HA-tagged forms of Gag. eIF4E served as loading control.
(G) Kif4 is required for HIV-1-induced MT stabilization. NHDF cells were transfected with control or Kif4 siRNAs and then infected with HIV-1-VSV for 6 hr. Fixed
samples were stained for AC-MTs (green) and Tyr-MTs (red). Nuclei were stained with Hoechst. Scale bar = 10 mm.
(H and I) Kif4 is required for HIV-1 infection. NHDFs were transfected with control or Kif4 siRNAs and then infected with HIV-1-VSV-luc (H) or HIV-1-Ampho-luc (I).
Infectivity was determined by measurement of luciferase activity 48 h.p.i.
(J and K) Effects of Kif4 depletion on HIV-1 DNA synthesis. Control or Kif4 siRNA-treated cells were infected with HIV-1-VSV-puro, and levels of viral MSS-DNA (J)
and total viral DNA (K) in samples were measured by qPCR. Data in H–K are represented as mean ± SEM. See also Figure S4.
Cell Host & Microbe
Microtubule Stabilization by HIV-1outward kinesin motor, its ability to regulate MT stability, shown
here, likely contributes to late-stage infection and could explain
its positive effects on both early inward and late outward stages
of infection.
Our findings demonstrate that an important aspect of early
retroviral infection involves the induction of specialized stable
MT subsets. We show that the highly specialized host MT end-
binding protein, EB1, and its binding partner, Kif4, act as critical
host mediators of these events and demonstrate that these544 Cell Host & Microbe 14, 535–546, November 13, 2013 ª2013 Elspoorly understood MT subsets facilitate the delivery of viral
particles to the nucleus.EXPERIMENTAL PROCEDURES
Cells and Viruses
293A, 293T, and CHME3 cells were described previously (Henning et al.,
2010). NHDFs were from Lonza. U87.CD4.CCR5 cells were from the AIDS
Reagent Program (#4035). Jurkats were from ATCC (#TIB-152). Primaryevier Inc.
Cell Host & Microbe
Microtubule Stabilization by HIV-1monocyte-derivedmacrophages were prepared as described previously (Jou-
venet et al., 2006). HIV-1-based vectors carrying a puromycin resistance gene
were produced as described previously (Naghavi et al., 2007). Generation of
HIV-1 carrying either a luciferase reporter (pNL4-3.Luc.R.E) or ZsGreen
marker (pNL4-3.ZsGreen.R.E), pseudotyped with CCR5 tropic, VSV-G, or
MuLV amphotropic envelope glycoprotein, is described in the Supplemental
Information. Vpr-labeled viruses were generated similarly by cotransfecting
with GFP-Vpr plasmid (McDonald et al., 2002). Mock and nonenveloped virus
preparations were generated by transfecting cells without DNA or excluding
plasmids for envelope glycoprotein, respectively. At 48 hr posttransfection,
culture supernatants were harvested, filtered through a 0.45 mm filter, concen-
trated by ultracentrifugation through a 25% sucrose cushion, and resus-
pended in growth medium.
Infections and Fusion Assays
Cells were infected with different dilutions of HIV-1-VSV-luc or HIV-1-Ampho-
luc (1:6000 and 1:2400, respectively), lysed 48–72 h.p.i., and assayed for lucif-
erase activity as described (Henning et al., 2010). Infection by puromycin- or
neomycin-expressing viruses was measured by colony counting after selec-
tion in puromycin (0.5 mg/ml) or geneticin (1 mg/ml). Pseudotyped HIV-1-
zsGreen virus was quantified (see Supplemental Information), dilutions were
used such that cells were infected at moi 3, and 85%–95% of cells were
ZsGreen positive. An moi of 1 was used for HIV-1-GFP-Vpr infections. Total
numbers of viral particles in preparations were estimated by serial dilution of
virus and WB analysis of p24 levels against known amounts of purified p24.
Virion-based fusion assays were performed as described (Cavrois et al.,
2002), with minor modification using ZsGreen-HIV-1-VSV containing the
BlaM-Vpr fusion protein (Addgene plasmid 21950). Sample processing is
described in the Supplemental Information.
RNAi and Nocodazole Treatment
Cells were transfected on two consecutive days with siRNA duplexes from
Ambion (EB1-II [#3891], EB1-III [#136501], Kif4 [#118455], or control GFP
siRNA) using RNAiMax (Invitrogen) (Henning et al., 2010). Cells were then
seeded, infected, and processed as described in the Results. For nocodazole
experiments, cells were rinsed with PBS and growthmedium containing noco-
dazole (Sigma) or DMSO control was added as indicated in the Results. Cells
were infected with HIV-1-zsGreen for 4 hr in the presence of nocodazole or
DMSO, and then medium was replaced with fresh drug-containing medium.
At 48 h.p.i., cultures were harvested, fixed with 4% paraformaldehyde, and
analyzed by fluorescence-activated cell sorting (FACS) using a Guava easy-
Cyte 8HT Flow Cytometer (EMD Millipore) and FlowJo Software (Tree Star).
qPCR Measurement of mRNAs and Viral DNA
Cytoplasmic RNAwas reverse transcribed into cDNA and used as template for
PCR (Naghavi et al., 2007). EB1 transcript levels were determined using
primers 3 and 9 in Table S1. To quantify viral DNA, cells were infected at a
high moi with HIV-1-VSV-puro or HIV-1-Ampho-puro as described (Henning
et al., 2010). As negative controls, cells were infected with equal amounts of
virus that was heat inactivated at 56C for 30 min. Hirt DNA was isolated at
24 h.p.i., and the amount of HIV-1MSS-DNA and total viral DNAwasmeasured
using primers specific to MSS and puromycin; copy numbers were interpo-
lated from detection threshold (CT) values using a full-length HIV-1, pNL4-3,
or a puromycin standard curve (Henning et al., 2010).
Antibodies, Western Blotting, and CoIP
Antibodies used were EB1 (sc-47704) and GAPDH (sc-25778) from Santa
Cruz; Flag (F7425), Kif4 (K1765), and acetylated tubulin (T7451) from Sigma;
tyrosinated tubulin (ab6160), HIV-1 p24 (ab9071), HIV-1 Gag (ab63917), and
GFP (ab13970) from Abcam; detyrosinated tubulin (AB3201) from EMD Milli-
pore; eIF4E (610269) from BD Biosciences; and PABP1 (4992) from Cell
Signaling Technology. For WB analysis, primary antibodies were used at a
1:1,000 dilution and detected using the appropriate horseradish peroxidase
(HRP)-conjugated secondary. For coIP, HeLa cells were transfected with
hemagglutinin (HA)-tagged forms of Gag, generated as described in the Sup-
plemental Information. After 48 hr, soluble cell extracts were prepared as
described previously (Henning et al., 2010) and precleared with protein G
Sepharose. Input samples were taken, and the remainder of the sample wasCell Host &incubated with mouse anti-Kif4 antibody and protein G Sepharose for 2 hr at
4C. Immune complexes were then washed and boiled in Laemmli buffer.
IF and Microscopy
Cells were grown on glass coverslips and fixed with ice-cold methanol, then
blocked and permeabilized with PBS supplemented with 2% BSA, 10%
FBS, and 1% Triton X-100. Samples were incubated with primary antibody
overnight at 4C, washed, and incubated with the appropriate Alexa Fluor-
conjugated secondary for 1 hr at room temperature. Images were acquired
using a Zeiss LSM 710 confocal laser scanning microscope or motorized spin-
ning-disc confocal microscope (Yokogawa CSU-X1 A1 confocal head and
Zeiss Axio Observer Z1 microscope). Orthogonal views were created using
SlideBook three view. Processing and distance measurements were done
using SlideBook Software (Intelligent Imaging Innovations). Intensity measure-
ment of stable MTs was done by intensity-based segmentation using the
Ridler-Calvard thresholding method. For TIRF microscopy, cells were stained,
mounted in Tris-buffered saline (TBS), and imaged on a Nikon TE2000 micro-
scope with a 603, 1.45 objective and an Orca II ER CCD (Hamamatsu) camera
controlled by MetaMorph Software (Wen et al., 2004).
Expression Constructs and Stable Lines
Expression constructs for C-terminally HA-tagged HIV-1 Gag, MA, Gag
mutants in MA, and HA-tagged SIV MA are described in the Supplemental
Information. MoMuLV vectors encoding Flag, EB1-Flag, or EB1-C-Flag were
generated as described in the Supplemental Information and used to infect
CHME3 cells. Lines stably expressing Flag, EB1-Flag, or EB1-C-Flag were iso-
lated by selection as described (Henning et al., 2010).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.chom.2013.10.012.
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